Scientists probe why scleroderma and lung hypertension weaken the heart
NCT ID NCT04610788
First seen Jan 10, 2026 · Last updated Apr 28, 2026 · Updated 16 times
Summary
This study looked at 43 people with scleroderma or unexplained pulmonary arterial hypertension (PAH) to understand why their right heart weakens. Researchers collected blood and tissue samples during routine procedures and measured heart function over six months. The goal was to learn how standard PAH treatments affect the right ventricle, not to test a new therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins
Baltimore, Maryland, 21287, United States
Conditions
Explore the condition pages connected to this study.